Google’s YouTube and Snap Inc. reached agreements to settle the first lawsuit headed to trial over claims that addiction to top social media platforms has disrupted learning and pushed public schools to spend massive sums fighting a mental health crisis, according to court filings. TikTok and Meta Platforms Inc. were also sued by the rural Kentucky school district that brought the case, which is set to go to trial on June 12 in federal court in Oakland, California. The trial will serve as a test case for more than 1,200 similar lawsuits nationwide in which school districts allege that the biggest social media companies have harmed students so badly that it’s undermining the education system. The spate of lawsuits could open the tech companies to a “collective theoretical liability of almost $400 billion,” according to an estimate from Bloomberg Intelligence. The terms of the settlements weren’t disclosed in Friday’s filings. “For more than a decade, we’ve built YouTube responsibly — working with teachers, administrators, and parents’ groups to give students safer, more helpful experiences online,” a YouTube spokesperson said in a statement. “This matter has been amicably resolved and our focus remains on building age-appropriate products and parental controls that deliver on that promise.” The settlements are the latest in what has been a busy year for child safety-related litigation . TikTok and Snap previously settled a first-of-its-kind personal injury suit over social media addiction shortly before it went to trial in Los Angeles earlier this year. Meta and Google did not settle, and a jury found them liable for harming a 20-year-old woman with products designed to be addictive. Meta also lost a separate case in New Mexico alleging the company failed to protect children from online predators; jurors assessed a penalty of $375 million on Meta. The four social media companies face thousands of additional lawsuits from school districts, state attorneys general and ...

中央气象台5月16日06时继续发布暴雨黄色预警：预计，5月16日08时至17日08时，河北南部、河南西部、山西中南部、陕西中南部、湖北中西部、湖南西北部、贵州北部、四川东部、重庆北部、广西东部、广东南部、海南岛东部等地部分地区有大到暴雨，其中，广西东南部沿海、广东南部沿海、海南岛东北部等地部分地区有大暴雨（100～240毫米）。上述部分地区伴有短时强降水（最大小时降雨量20～50毫米，局地可超过70毫米），局地有雷暴大风等强对流天气。（中央气象台）

中央气象台5月16日06时继续发布大雾黄色预警：预计，5月16日08时至17日08时，渤海海峡、黄海大部海域、辽东半岛东部沿岸海域、山东半岛东部沿岸海域、江苏沿岸海域将有能见度不足1公里的大雾。此外，16日早晨至上午，四川东部、贵州西部、湖南西部等地的部分地区有大雾，局地有能见度不足500米的浓雾。（中央气象台）

DAL, M, AMZN, V, And UNH Stocks In Focus As Berkshire Rejigs Portfolio Stocktwits

Key Takeaways Optiver US LLC's substantial $6 billion increase in Amazon (AMZN) exposure highlights a strong institutional conviction in the tech giant's long-term growth, particularly in its high-margin segments. increase in Amazon (AMZN) exposure highlights a strong institutional conviction in the tech giant's long-term growth, particularly in its high-margin segments. Amazon's Q1 2026 results demonstrated robust top-line growth of 17% and a record 13.1% operating margin, propelled by AWS's 28% expansion and continued advertising strength. results demonstrated robust top-line growth of and a record operating margin, propelled by expansion and continued advertising strength. Despite heavy $200 billion capital expenditures for AI infrastructure impacting free cash flow, Wall Street analysts maintain a "Buy" consensus with price targets suggesting significant upside from current levels. Why is Optiver Betting Big on Amazon (AMZN) Now? Optiver US LLC, a prominent high-frequency trading and market-making firm known for its sophisticated algorithmic strategies, has dramatically increased its exposure to Amazon (AMZN), adding over $6 billion in new capital to make it a top holding. This isn't a casual portfolio adjustment; it signals a deep-seated conviction in Amazon's future trajectory, especially given Optiver's strategic focus on technological leverage and expanding U.S. market-making capabilities. Their move suggests a belief that Amazon's underlying fundamentals and growth catalysts are compelling enough to warrant such a substantial investment. The timing of Optiver's increased stake coincides with a dynamic period for Amazon shares. As of May 15, 2026, AMZN trades at $264.14, reflecting a slight daily dip of -1.15% from its previous close of $267.22. This follows a remarkable run where the stock surged 27% in the last month, positioning it as the best-performing "Magnificent Seven" stock year-to-date. This recent rebound comes after a challenging period earlier i...

PM Images/DigitalVision via Getty Images Introduction The Dividend Champions list is a monthly compilation of companies that have consistently increased their annual dividend payouts. However, since this list is only produced once per month, the data in it can quickly get out of date. Furthermore, with around 700 companies on the list, the sheer amount of data can quickly become overwhelming. In this weekly series, I highlight recent and upcoming dividend-related activity for dividend stocks on the Dividend Champions list. In the data presented below, Yield is forward annualized, and Years reflects the up-to-date streak, including dividends declared since the last edition of the Dividend Champions list. Dividend Changes In the past week, the following companies declared dividends that changed from their previous payouts. Increases: Company Symbol Ex-Div Pay Old Rate New Rate Increase Yield Years Muncy Columbia Financial Corporation ( CCFN ) 5/26 6/11 0.153333 0.155 1.09% 2.38% 29 Curtiss-Wright Corporation ( CW ) 6/15 7/6 0.24 0.26 8.33% 0.15% 10 Farmers & Merchants Bancorp ( FMCB ) 6/12 7/1 5.1 5.35 4.90% 1.59% 63 Hyster-Yale Materials Handling, Inc. ( HY ) 6/1 6/16 0.36 0.365 1.39% 4.09% 15 NACCO Industries, Inc. ( NC ) 6/1 6/15 0.2525 0.2625 3.96% 2.13% 41 Penske Automotive Group, Inc. ( PAG ) 5/26 6/3 1.4 1.42 1.43% 3.50% 6 RLI Corp. ( RLI ) 5/29 6/12 0.16 0.18 12.50% 1.42% 51 Click to enlarge Decreases: None Last Chance To Buy These dividend growth stocks have ex-dividend dates approaching. The following tables indicate the last day you can buy these stocks in order to be eligible for the upcoming dividend. Tables are sorted alphabetically by symbol. Monday, May 18 (Ex-Div 5/19) Company Symbol Pay Date Payout Price Yield Years Avista Corporation ( AVA ) 6/12 0.4925 40.41 4.88% 24 BWX Technologies, Inc. ( BWXT ) 6/5 0.27 204.72 0.53% 11 Chevron Corporation ( CVX ) 6/10 1.78 191.10 3.73% 39 Fresh Del Monte Produce Inc. ( FDP ) 6/11 0.3 32.49 3.69% 6 Innospec Inc....

Key PointsMonimus bought 241,918 ZD shares in the first quarter; the estimated trade size was $8.90 million based on quarterly average prices.

以色列及黎巴嫩代表在美國舉行第三輪會談，以黎同意延長停火45天。 以色列及黎巴嫩駐美國大使周五繼續在美國國務院會談，據報以黎雙方仍有重大分歧。黎巴嫩希望先實現全面停火，之後討論以軍撤離。至於黎巴嫩真主黨武裝問題，就在停火後，由黎巴嫩內部以政治途徑解決。不過，以色列主張談判目標就是解除真主黨武裝。 美國國務院在周五表示為了談判取得進展，以黎停火協議將延長45天。以黎雙方早在上月17日開始停火，期間以軍繼續攻擊黎巴嫩南部的真主黨據點。真主黨就發射無人機還擊，累計有數百人死亡。

Mohammad Baqer Saad Dawood al-Saadi appeared in US federal court to face six terrorism-related charges The US justice department has arrested and charged an Iraqi national accused of involvement in nearly 20 alleged terror attacks and attempted attacks across the US and Europe . The wave of violence attributed to Mohammad Baqer Saad Dawood al-Saadi has caused huge concern in many European countries but especially the UK, where Jewish community centres, charities, synagogues and other sites have been targeted in recent weeks. Continue reading...

Omega Fund Management cut its stake in Kestra Medical Technologies (NASDAQ:KMTS) , selling 351,442 shares in the first quarter for an estimated $8.28 million based on quarterly average pricing, according to a May 15, 2026, SEC filing. According to an SEC filing published May 15, 2026, Omega Fund Management decreased its position in Kestra Medical Technologies, Ltd. by 351,442 shares during the first quarter. The estimated transaction value was $8.28 million, calculated using the average unadjusted closing price for the quarter. The fund’s quarter-end holding was 1,022,149 shares, with a reported value of $20.37 million. Kestra Medical Technologies, Ltd. is a healthcare technology company specializing in advanced wearable devices and digital platforms for cardiac patient management. The company leverages intelligent, connected solutions to support both patients and providers, aiming to enhance clinical outcomes in cardiovascular disease. With a focus on innovation and integration, Kestra develops next-generation cardiac monitoring and intervention solutions. Continue reading

美國跟伊朗談判未見進展，伊朗外長阿拉格齊稱美方只要展現誠意，準備達成公平協議才可談判，亦不排除將濃縮鈾移交俄羅斯。美國總統特朗普就稱無意尋求中國向伊朗施壓，又稱德黑蘭當局只要願意20年內暫停核計劃及提煉濃縮鈾，美方亦會接受。 伊朗外長阿拉格齊周五在印度首都新德里，出席金磚國家外長會議期間指伊朗與美國談判未見進展，原因之一是美國不斷發表不理智及自相矛盾的言論。阿拉格齊指責美國總統特朗普有時候稱不能夠接受，伊朗就美國和平方案的回覆，有時候又稱願意跟德黑蘭談判。他表明伊朗及美國缺乏互信，若果美方準備達成公平協議，伊朗願意繼續推進談判。 阿拉格齊強調，伊朗不尋求發展核武，並透露伊朗濃縮鈾材料一直是棘手問題，伊美雙方同意暫時擱置討論。若果伊朗將來要運走濃縮鈾交由其他國家處置，當局願意跟俄羅斯磋商。 外長王毅本月6日在北京會晤到訪的阿拉格齊，阿拉格齊指伊中兩國關係很好，德黑蘭當局知道中方懷著善意，歡迎中方努力以外交途徑，解決當前問題。 美國總統特朗普結束國事訪問中國之後在空軍一號專機向記者表示，他跟國家主席習近平都支持重開霍爾木茲海峽，並反對伊朗發展核武。特朗普強調，沒有要求中方向伊朗施壓，美方不需要北京協助。 美國總統特朗普說︰「我沒有要求任何幫忙，因為你要求幫忙就要回報對方，我們不需要幫忙。」 特朗普又稱，若果伊朗保證20年內不再提煉濃縮鈾及發展核武，他願意接受這方案，前提是伊朗必須真誠地履行協議。

《诸病源候论》卷二十七：「谓人皮肤上，如蛇皮而有鳞甲，世谓之蛇身也。」 「蛇皮癣」这个病可能很多人都听过，但是你对它的了解有多少呢？「蛇皮癣」的学名叫「鱼鳞病」，大家又有没有听过？ 注册中医师何慧洁说：「我们叫它做蛇身、蛇胎或者蛇皮，顾名思义，其实是皮肤上会有些蛇皮，或者好像有鳞甲这样的东西，覆盖在我们的四肢，手和脚上面。但是最常见的就会在小腿胫前的地方，会有一些多角形或者菱形的一些很厚的、角质性的一些表现。」 寻常型鱼鳞病是中医最常见的，这个病与遗传有关，征状因人而异，严重的患者，可能一年四季皮肤都非常干燥。 何慧洁称：「鱼鳞病在中医角度来说是和热、阴虚和血虚最大关联。譬如热，一个人很热气的话，它会导致我们身体里面的阴份和血份受到烧灼，而导致不足，当我们血液和津液，不可以上荣于皮肤表面的时候，就会形成一些很干燥的皮肤。」 中医会通过望闻问切，去观察患者的鱼鳞病是由甚么元素导致，不同征状的患者，会有不同的治疗方案，例如针对热症患者，就会使用清热、养血的药物，改善皮肤的滋润度，减轻患者痕痒不适的感觉。 何慧洁指出：「除了内服的药物之外，我们都会针对皮肤的状态，建议患者使用一些外用的药物，很多时候我们会建议患者使用含有当归的一些外用药膏，例如紫云膏，因为当归可以让局部的血液循环改善，亦可以滋润皮肤，让他们鱼鳞病的症状减轻。有时候我们都会使用针灸，改善患者的气血循环，可改善皮肤局部的情况，那我们选取的穴位都比较多是下肢的地方，包括是有一些补血作用的穴位，包括血海、阴陵泉、三阴交等。」 中医师提醒，患者日常要避免使用很热的水洗澡，洗澡之后也可以适量搽一些润肤膏，亦要减少吃一些刺激性的食物，以免病情加重。 今次为大家推介一款养血润肤汤，有助改善血液循环，增加皮肤润泽度。 材料： 当归 6克 熟地 15克 川芎 6克 雪耳 1朵 煮法：雪耳清水浸两小时后，加入其余药材及八碗水，大火煮滚后，转小火煮三十分钟即可。 点击观看节目重温

Key PointsOnto Innovation powers AI chip production through critical defect inspection and metrology systems.

格隆汇5月16日｜据委内瑞拉国家石油公司（PDVSA）、事故报告、相关消息人士及现场视频显示，周五委内瑞拉马拉开波湖（Lake Maracaibo）的一处天然气加工设施发生剧烈爆炸并引发火灾，造成六名工人受伤，并导致工厂受损。

Final trade: ALL, ROSS, MSFT, ULTA MSN

Key PointsMonimus Capital bought 2,053,088 Tripadvisor shares in the first quarter; the estimated trade value was $23.91 million based on quarterly average prices.

Kentucky Derby-Winning trainer Cherie DeVaux joins the show to discuss the decision not to run Golden Tempo in the Preakness. She discusses the timeline between the races which played a factor in her decision to withdraw from the race. She speaks with Katie Greifeld & David Papadopoulos on “The Close.” (Source: Bloomberg)

Source: Bloomberg, 4:33

Billionaire investor Bill Ackman’s Pershing Square disclosed a new position in Microsoft ( MSFT ) and reduced its stake in Uber Technologies ( UBER ), among its first quarter moves. The fund disclosed this information in its latest 13F filing on Friday. Pershing holds a stake of 5.65M shares in Microsoft, as per the filing. Earlier in the day, Ackman called the tech giant “highly compelling” at current valuations. "We believe Microsoft's recent share price decline has been principally driven by investor concerns around two key issues: i) the competitive positioning of M365 against increasingly capable AI lab offerings (notably Anthropic's Claude Cowork), and ii) the durability of Azure's growth, especially in light of Microsoft's evolving relationship with OpenAI ( OPENAI )," Ackman said in a post on X . Pershing decreased its position in Uber Technologies ( UBER ) to 29.95M shares from 30.2M during the quarter. The fund now holds 2.66M shares of Meta Platforms ( META ), down from 2.67M shares. The firm reduced its Alphabet Class C shares ( GOOG ) from more than 6.1 million shares in Q4 2025 to 311,726 shares in Q1 2026. Alphabet Class A holdings ( GOOGL ) also reduced quarter-over-quarter. Lastly, the fund has exited its position in Hilton Worldwide Holdings ( HLT ) during the first quarter. More on 13Fs Ray Dalio's Bridgewater Associates exits Salesforce, cuts stake in PayPal in Q1 Corvex Management adds CoStar Group, Lionsgate Studios, and exits Oracle among Q1 moves Tiger Global takes new position in Intel; adds to Broadcom, Nvidia among Q1 moves Berkshire Hathaway dumps Visa and Mastercard, adds Delta Air and Macy's in Q1 3G Capital adds semiconductor stocks, doubles holding in Alibaba among Q1 positioning changes

YouTube is expanding its AI likeness detection program to all users over the age of 18 - meaning just about anyone can have the platform hunt for potential deepfakes of themselves. The likeness detection feature uses a selfie-style scan of a person's face to monitor YouTube for lookalikes. If there is a match, YouTube alerts the user; the person then has the option to request that YouTube remove the content. YouTube has said in the past that it has found the number of removal requests to be "very small." YouTube began testing the feature with content creators , and then expanded it to government officials, politicians, journalists, and fina … Read the full story at The Verge.

Closing Arguments In High-Stakes OpenAI Trial Focus On Reputation, Character Authored by Beige Luciano-Adams via The Epoch Times (emphasis ours), OAKLAND, Calif.—After nearly three weeks of presented evidence, an Oakland jury on May 14 heard final arguments in a high-stakes legal battle that could have profound impacts on the race for artificial intelligence. In a courtroom sketch, Sam Altman listens as OpenAI President Greg Brockman testifies during Elon Musk's lawsuit trial over OpenAI's for-profit conversion, at a federal courthouse in Oakland, Calif., on May 4, 2026. Vicki Behringer/Reuters Tech moguls Elon Musk and Sam Altman, once friends and partners in a fledgling AI startup with big dreams and a noble mission, are nearing the climax of a bitter feud over the future of an $852 billion company. Despite a judicial ban on testimony related to AI-induced “extinction” scenarios, references to speculative risks still surfaced during the Oakland courtroom proceedings, appeared in discussions around “risk” and “safety.” Vague promises about the future benefits of an unrealized technology were also touched upon. On the stand, Tesla CEO Musk told the court, “We don’t want to have a Terminator outcome,” suggesting humanity would be better off with a “Star Trek” future written by Gene Roddenberry, rather than something from the mind of James Cameron. Musk cofounded OpenAI in 2015 with Altman, President Greg Brockman, and former chief scientist Ilya Sutskever. At the time, both Musk and Altman expressed grave concerns about the unregulated advancement of Artificial General Intelligence (AGI)—a hypothetical point at which the machines “outsmart” humans and operate autonomously. Those concerns, Musk testified, were the express motivation for founding OpenAI: open-source to prevent consolidation of power, and philanthropic to offset the profit-driven AI race. He sued Altman and Brockman in 2024, alleging they bilked him out of $38 million in donations, then restructured as ...

美国总统特朗普称赞股市。

Key PointsGemini published its first-quarter results yesterday and reported a wider-than-expected loss on sales that beat Wall Street's target.

Enbridge President & CEO Greg Ebel discusses the agreement between Canada and the Alberta province about the carbon tax deal. He discusses the ramifications for future pipelines in the country and how it can affect North America at large going forward. He speaks with Katie Greifeld & Isabelle Lee on “The Close.” (Source: Bloomberg)

Jian Fan/iStock via Getty Images Inventiva S.A. ( IVA ) is a late-stage clinical biopharmaceutical company developing oral small-molecule therapies. Concretely, they’re targeting metabolic dysfunction-associated steatohepatitis, or MASH, formerly known as NASH. Their lead candidate is lanifibranor, which is a MASH and advanced fibrosis treatment. This candidate is in Phase 3 NATiV3 trials, and its topline results should be ready by Q4 2026. IVA believes this trial will confirm and corroborate the previously positive Phase 2 results. If this happens, this could support potential NDA and MAA regulatory submissions by 1H2027. In my view, this positions IVA as an inherently speculative bet at this stage, yet the upside potential is commensurate. So, I lean bullish on the shares for long-term investors willing to bet on the Q4 data. A Bet On Lanifibranor Inventiva S.A. is a late-stage biopharmaceutical that’s targeting several diseases through its candidates. However, the main focus should be on their MASH asset, which I believe has the most potential. They were founded back in 2011 and are currently headquartered in Daix, France. Since then, they’ve narrowed down their pipeline towards lanifibranor. This is their Phase 3 NATiV3 readout, and if this asset remains differentiated through their upcoming Q4 readout , it could make IVA a worthwhile speculative play today. As such, I felt it was worthwhile analyzing this otherwise underfollowed name. Source: Corporate Presentation. March 2026. As a quick recap, IVA’s lead asset is lanifibranor . Technically speaking, this is an oral pan-PPAR agonist designed to produce anti-fibrotic, anti-inflammatory, and metabolic effects in MASH. Unfortunately, MASH is a chronic liver condition associated with steatosis, inflammation, liver-cell injury, and fibrosis. IVA now has lanifibranor in NATiV3, which is a Phase 3 trial with adult MASH patients with advanced fibrosis. IVA anticipates this trial’s topline results will be ready by Q4 2...

格隆汇5月16日｜刚果（金）政府15日发布声明说，该国东部伊图里省暴发的新一轮埃博拉疫情致死人数已升至80人，另有246例疑似病例。

格隆汇5月16日｜第二艘国产大型邮轮“爱达·花城号”今天（16日）从中船集团上海外高桥造船5号码头启航，开始为期12天的试航任务。本次试航任务，工作人员将对第二艘国产大型邮轮“爱达·花城号”建造质量与系统可靠性进行实战检验，通过对减摇鳍等系统及设备的试验，同步验证振动噪声、航速等关键指标，以达到验证邮轮安全性、舒适性、可靠性的目的。按计划，第二艘国产大型邮轮“爱达·花城号”将在试航结束后逐步向船东完成项目报验，计划于2026年11月6日完成交付，交付后将从广州南沙国际邮轮母港开启首航季。

Earnings Call Insights: BioCardia (BCDA) Q1 2026 Management View "We have had significant accomplishments this last quarter for our CardiAMP Cell Therapy for the treatment of ischemic heart failure" (CEO, President & Director Peter Altman), highlighting FDA breakthrough designation and "Medicare reimbursement at $20,000 per treatment procedure today." "In our formal clinical consultation with Japan's Pharmaceutical and Medical Devices Agency, they have said that they are inclined to accept this data as the basis for regulatory submission and approval in Japan" (CEO, President & Director Altman), adding that BioCardia has already received "the draft written advisory record from the agency" and is preparing a Shonin submission. "We also completed a Q-Sub meeting with FDA Center for Biologics Evaluation and Research" (CEO, President & Director Altman), stating FDA "view the appropriate approval pathway as a premarket approval," "had no concerns on the safety," and "encouraged BioCardia to complete the ongoing CardiAMP HF II trial" while engaging on elements of statistical analysis. "For the second quarter of 2026, looking ahead, we expect to complete one or more transactions that will fund Japan PMDA submission for approval and the CardiAMP Heart Failure II trial" (CEO, President & Director Altman). "Total expense decreased by $460,000 quarter-over-quarter to $2.3 million" (Chief Financial Officer David McClung), and "the company ended the quarter with cash and cash equivalents totaling $951,000." Outlook BioCardia said it "expect[s]" the Japan Shonin application "will take approximately 7 months to prepare and submit" (CEO, President & Director Altman) and described a post-submission "about a year-long review process" (CEO, President & Director Altman). Management’s near-term priorities were framed as execution and financing, with the CEO stating: "Completing the CardiAMP Shonin premarket application for approval in Japan and enrolling CardiAMP Heart Failure II are ou...

【有線新聞】阿聯酋職業足球聯賽，艾華斯爾主場2比1擊敗卡爾巴。 以聯賽5連勝為球季作結，黃衫的艾華斯爾開賽10分鐘「收大禮」。對方門將艾文菲利將皮球拍落麥素身上，變成「烏龍波」。 聯賽最後一場，兩隊都已鎖定名次。史柏達斯奧為成功護級的卡爾巴，20分鐘追平。換邊後的79分鐘，米基爾保查後備落場1分鐘，就為應屆季軍艾華斯爾建功，贏2比1，取得來季亞洲賽資格。

Investors have spent the past year glued to every Federal Reserve press conference and Treasury auction. The 10-year Treasury yield sits at 4.46% as of May 13, 2026, up 0.16% from a month ago, and the federal funds rate has held at 3.75% since December 11, 2025 after three 0.25% cuts in the fall. Andrew ... Stop Obsessing Over Interest Rates. Focus on These 3 Moves Instead